HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Angelos Karlas Selected Research

Angelos Karlas Research Topics

Disease

4Neoplasms (Cancer)
11/2021 - 09/2016
3Inflammation (Inflammations)
01/2023 - 02/2019
3Breast Neoplasms (Breast Cancer)
11/2021 - 12/2020
2Carotid Artery Diseases
01/2023 - 09/2021
2Stroke (Strokes)
01/2023 - 11/2022
2Hypoxia (Hypoxemia)
11/2021 - 12/2020
2Peripheral Arterial Disease
01/2021 - 02/2019
2Type 2 Diabetes Mellitus (MODY)
11/2018 - 10/2018
2Obesity
11/2018 - 10/2018
1Diabetes Mellitus
09/2023
1Diabetes Complications
09/2023
1Hemorrhage
01/2023
1Insulin Resistance
01/2023
1Myocardial Infarction
01/2021
1Ventricular Tachycardia
01/2021
1Graves Disease (Basedow Disease)
10/2019
1Thyroid Nodule (Nodule, Thyroid)
10/2019
1Carotid Stenosis (Carotid Artery Stenosis)
02/2019
1Abdominal Aortic Aneurysm
02/2019
1Metabolic Diseases (Metabolic Disease)
01/2019
1Vascular Malformations
12/2018
1Rupture
12/2018
1Dyslipidemias (Dyslipidemia)
10/2018
1Glucose Intolerance
10/2018
1Body Weight (Weight, Body)
10/2018
1Atherosclerotic Plaque (Atheroma)
09/2016

Drug/Important Bio-Agent (IBA)

7Hemoglobins (Hemoglobin)IBA
01/2023 - 12/2018
4Biomarkers (Surrogate Marker)IBA
09/2023 - 12/2018
4LipidsIBA
01/2023 - 12/2018
2Coloring Agents (Dyes)IBA
01/2023 - 11/2021
2Contrast MediaIBA
01/2021 - 01/2019
2CollagenIBA
02/2019 - 09/2016
2Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA
11/2018 - 10/2018
1Insulin (Novolin)FDA Link
01/2023
1Retinaldehyde (Retinal)IBA
11/2022
1Doxorubicin (Adriamycin)FDA LinkGeneric
11/2021
1CaspasesIBA
11/2021
1Docetaxel (Taxotere)FDA Link
01/2021
1DiureticsIBA
01/2021
1Oxygen (Dioxygen)IBA
01/2021
1Anti-Arrhythmia AgentsIBA
01/2021
1pimonidazoleIBA
12/2020
1Bevacizumab (Avastin)FDA Link
12/2020
1Biocompatible Materials (Biomaterials)IBA
02/2019
1ElastinIBA
02/2019
1icilinIBA
10/2018
1Dimethylphenylpiperazinium IodideIBA
10/2018
1Fluorescent Dyes (Fluorescent Probes)IBA
09/2016

Therapy/Procedure

4Therapeutics
01/2023 - 12/2018
2Drug Therapy (Chemotherapy)
11/2021 - 01/2021
1Aftercare (After-Treatment)
12/2018